Leave a Reply

Next Post

Regeneron CEO says U.S. secured 300,000 doses of antibody cocktail

Washington — Dr. Leonard Schleifer, the founder and CEO of Regeneron Pharmaceuticals, which developed the antibody cocktail heralded by President Trump, estimated Sunday that a $450 million contract the company won from the federal government over the summer will secure roughly 300,000 doses of the treatment. “They bought from us […]